Skip to main content
Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
0.584
-0.016 (-2.68%)
At close: Apr 28, 2026, 4:00 PM EDT
0.565
-0.019 (-3.32%)
Pre-market: Apr 29, 2026, 7:29 AM EDT

Scinai Immunotherapeutics Revenue

In the year 2025, Scinai Immunotherapeutics had annual revenue of $1.31M with 99.24% growth. Scinai Immunotherapeutics had revenue of $269.00K in the quarter ending December 31, 2025, with 30.58% growth.

Revenue (ttm)
$1.31M
Revenue Growth
+99.24%
P/S Ratio
1.54
Revenue / Employee
$42,290
Employees
31
Market Cap
2.03M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.31M653.00K99.24%
Dec 31, 2024658.00K--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

SCNI News

More News